Printer Friendly
The Free Library
14,669,765 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

INC Research Represented on DIA Board of Directors.


Dr. Sergio Guerrero Elected to DIA Board to Help Expand Drug Development Efforts in Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies.  

RALEIGH, N.C. -- INC Research INC Research is a contract research organization headquartered in the North Carolina Research Triangle in Raleigh, North Carolina, United States.[1] The company has 26 locations in 36 countries. , a therapeutically-focused contract research organization (CRO) with a trusted process for delivering reliable results, is pleased to announce that Dr. Sergio Guerrero has been elected to the Drug Information Association (DIA) Board of Directors. Guerrero will not only represent INC Research, but also the interests of drug development activities in Latin America.

"We are very proud to have Dr. Guerrero elected to the DIA Board of Directors. The organization will benefit from his deep understanding of the developing clinical trials markets throughout Latin America," said John Pothoff, COO of INC Research. "He will be instrumental as the DIA expands its events and educational activities in the region."

DIA is a membership association involved in the discovery, development, regulation, surveillance, or marketing of pharmaceuticals or related products. As a multidisciplinary, neutral forum for sharing information, DIA aims to optimize the process of drug development and lifecycle management by providing global and regional forums for the exchange of information, education, and training. The association is featuring its 4th Latin American Congress of Clinical Research Global Initiatives of Clinical Research located in Sao Paulo in Sept. 27-29, 2007, which is now an annual meeting.

"I've been working with many Latin American clinical research groups and feel I can raise awareness of the issues surrounding drug development and clinical trials, such as human subject protection and training for investigator sites. Furthermore I am able to apply lessons learned and experience from INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
 Research's Trusted Process, which as a methodology-based approach is well suited to help establish standards in the region," said Guerrero, Latin America business associate at INC Research. "I am honored to be elected to this esteemed and globally-recognized association."

Guerrero joined INC Research in 2006 to identify and manage Latin American business opportunities, conduct feasibility studies The analysis of a problem to determine if it can be solved effectively. The operational (will it work?), economical (costs and benefits) and technical (can it be built?) aspects are part of the study. Results of the study determine whether the solution should be implemented.  for trials in Latin America, and build its Latin American investigator relationships and database.

As an MD and MBA MBA
abbr.
Master of Business Administration

Noun 1. MBA - a master's degree in business
Master in Business, Master in Business Administration
 with more than 10 years of experience in the clinical trials industry and more than 20 years in the medical community, Guerrero has experience in a variety of therapeutic areas and functional areas including site management, regulatory, project management and quality assurance. Guerrero's secondary goal as a member of the DIA Board is to work with the different local regulatory agencies regulatory agency

Independent government commission charged by the legislature with setting and enforcing standards for specific industries in the private sector. The concept was invented by the U.S.
 and create professional networks to help attract and foster new talent to the industry.

About INC Research([R])

INC Research is a therapeutically-focused contract research organization with an unrivaled reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
 look to INC Research for a complete range of customized Phase 1 - Phase 4 programs in therapeutic areas of specialty, and in innovative pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 trials. The company's Trusted Process[TM] methodology and therapeutic foresight (graphics, tool) Foresight - A software product from Nu Thena providing graphical modelling tools for high level system design and simulation.  leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina For other uses of this name, see Raleigh.
Raleigh (IPA: /ˈrɑli/, ral-ee) is the capital of the State of North Carolina and the county seat of Wake County.
, and now in 26 locations in 36 countries worldwide. For more information please visit www.incresearch.com
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 27, 2007
Words:509
Previous Article:Toshiba America Business Solutions Inc. Secures Certified for Windows Vista Logo for e-STUDIO(TM)2500c/3500c/3510c Multifunction Product Suite.
Next Article:Hyo Yeon Appointed GM of Schematic's NYC Office.
Topics:



Related Articles
Adams & Co. Real Estate recently brokered seven leases at 110 W. 40th St. for a total of 8,397 square feet.(NEW YORK)
Colliers ABR, Inc. announced that Susman Godfrey LLP, a Dallas-based premier litigation law firm, has signed a five-year lease for 7,400 s/f at 654...
SL Green has announced the following transactions.(NEW YORK)
Adams & Co. Real Estate completed the following transactions.(NEW YORK)
HK Group announced the following transactions.(CONNECTICUT)
Cushman & Wakefield, exclusive leasing agent to High Ridge Park Corporate Center in Stamford, announced that Wilmington Family Office signed a...
Plug-and-play facility attracts medical media company.(NEW JERSEY)
Goldstein closes sale of Time Equities retail property.(NEW JERSEY)
Field burning study the first step to a decision.(Editorials)(Editorial)
BUSINESS BEAT.(Business)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles